SMGIX
Price
$32.96
Change
+$0.71 (+2.20%)
Updated
Apr 24 closing price
Net Assets
13.13B
VFINX
Price
$506.43
Change
+$10.05 (+2.02%)
Updated
Apr 24 closing price
Net Assets
1.32T
Ad is loading...

SMGIX vs VFINX

Header iconSMGIX vs VFINX Comparison
Open Charts SMGIX vs VFINXBanner chart's image
Columbia Contrarian Core Inst
Price$32.96
Change+$0.71 (+2.20%)
VolumeN/A
Net Assets13.13B
Vanguard 500 Index Investor
Price$506.43
Change+$10.05 (+2.02%)
VolumeN/A
Net Assets1.32T
SMGIX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SMGIX vs. VFINX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMGIX is a Buy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.32T vs. SMGIX (13.1B). VFINX pays higher dividends than SMGIX: VFINX (1.24) vs SMGIX (0.57). SMGIX was incepted earlier than VFINX: SMGIX (32 years) vs VFINX (49 years). SMGIX (0.74) is less costly to investors than VFINX (0.14). SMGIX is a more actively managed with annual turnover of: 51.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than SMGIX: VFINX (0) vs SMGIX (2000). VFINX annual gain was more profitable for investors over the last year : 6.04 vs. SMGIX (-4.16). VFINX return over 5 years is better than : 89.57 vs. SMGIX (34.92).
SMGIXVFINXSMGIX / VFINX
Total Expense Ratio0.740.14529%
Annual Report Gross Expense Ratio0.740.14529%
Fund Existence32 years49 years-
Gain YTD-8.975-8.547105%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B1.32T1%
Annual Yield % from dividends0.571.2446%
Returns for 1 year-4.166.04-69%
Returns for 3 years7.1525.2228%
Returns for 5 years34.9289.5739%
Returns for 10 years49.54155.3632%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGLS2.800.25
+9.80%
Regulus Therapeutics
BOOT102.185.32
+5.49%
Boot Barn Holdings
EVGN1.110.02
+1.83%
Evogene Ltd.
RS285.162.05
+0.72%
Reliance
IMNM8.520.02
+0.24%
Immunome